XML 35 R25.htm IDEA: XBRL DOCUMENT v3.24.1.u1
STOCKHOLDERS’ EQUITY (Tables)
3 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Schedule of Stock-Based Compensation Expense
The following table summarizes stock-based compensation expense related to restricted stock units (“RSUs”), stock options, and Employee Stock Purchase Plan (“ESPP”) shares, which was allocated as follows (amounts in thousands):
Three Months Ended December 31,
 20232022
Cost of revenue$129 $126 
Selling and marketing820 491 
Research and development1,041 554 
General and administrative1,440 1,271 
Stock-based compensation expense included in expenses
$3,430 $2,442 
Schedule of Stock Option Activity
The following table summarizes stock option activity under the Company’s equity plans during the three months ended December 31, 2023:
Number of
Shares
Weighted-Average
Exercise Price
Weighted-Average
Remaining
Contractual Term
(in years)
Aggregate Intrinsic Value
(in thousands)
Outstanding at September 30, 2023651,269 $7.37 3.6$2,185 
Granted— $— 
Exercised(96,634)$8.85 169 
Canceled— $— 
Outstanding at December 31, 2023554,635 $7.11 4.03,291 
Vested and Expected to Vest at December 31, 2023554,635 $7.11 4.03,291 
Exercisable at December 31, 2023554,635 $7.11 4.03,291 
Schedule of RSU Activity
The following table summarizes RSU activity under the Company’s equity plans during the three months ended December 31, 2023:
 
Number of
Shares
Weighted-Average
Fair Market Value
Per Share
Outstanding at September 30, 20232,188,296 $11.49 
Granted1,078,233 11.16 
Settled(445,729)11.17 
Canceled(61,167)11.88 
Outstanding at December 31, 20232,759,633 11.40 
Schedule of Performance RSU Activity
The following table summarizes Performance RSU activity under the Company’s equity plans during the three months ended December 31, 2023:
 
Number of
Shares
Weighted-Average
Fair Market Value
Per Share
Outstanding at September 30, 2023730,393 $13.37 
Granted700,846 10.85 
Settled(187,454)11.23 
Canceled(40,582)13.31 
Outstanding at December 31, 20231,203,203 12.24